24/7 Emergency & General Advisory
π¨ 24/7 Medical Emergency
Non-Emergency Advisory
10:00 AM β 6:00 PM, MonβSat
For appointments & general queries.
Join our healthcare community
Stay updated with our latest healthcare news and your appointments.
Learn about Onpattro (patisiran) dosage, administration, and important considerations for treating hATTR amyloidosis. Understand how your dose is determined and what to expect during treatment.

Onpattro, with the active ingredient patisiran, is a prescription medication belonging to a class of drugs known as RNA interference therapy. It is specifically used in adults to manage and treat polyneuropathy, a condition characterized by widespread nerve damage, which is caused by hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis). hATTR amyloidosis is a rare genetic disorder where abnormal proteins, called amyloid fibrils, build up in organs and tissues, including nerves, leading to progressive damage.
Onpattro is not a medication you take orally. Instead, it is administered as an intravenous (IV) infusion. This means it is slowly injected into your vein over a period of time. The infusion is typically carried out by a qualified healthcare professional in a clinical setting, such as a hospital, infusion center, or doctor's clinic. The process usually takes about 80 minutes for each infusion session.
The standard administration schedule for Onpattro is once every three weeks. This consistent dosing is crucial for maintaining therapeutic levels of the medication in your body to effectively manage the symptoms of hATTR amyloidosis.
The dosage of Onpattro is not a one-size-fits-all approach. Your doctor will determine the precise dosage based on your individual body weight. This personalized approach ensures that you receive the most effective treatment while minimizing potential side effects.
It is essential to discuss your weight and any changes in it with your doctor, as this will directly influence your Onpattro dosage.
Missing a dose of Onpattro can happen, and it's important to know how to proceed. If you realize you've missed your scheduled dose within 3 days of when it was due, your healthcare provider will likely continue with your current dosing schedule. However, if more than 3 days have passed since your missed dose, your doctor will administer the missed dose and then adjust your future dosing schedule accordingly. Always communicate with your healthcare provider about any missed doses.
To help reduce the risk of infusion reactions, which are side effects that can occur during the Onpattro infusion, your doctor will administer certain medications about an hour before you receive Onpattro. These pre-medications may include:
These medications work together to make the infusion process safer and more comfortable.
While undergoing treatment with Onpattro, your doctor will likely recommend that you take a vitamin A supplement. This is a crucial recommendation because Onpattro can potentially lower the levels of vitamin A in your body. Low vitamin A levels can lead to vision problems, such as difficulty seeing at night. Taking a supplement helps to maintain adequate vitamin A levels and protect your vision.
Onpattro is generally considered a long-term treatment option for hATTR amyloidosis. If you and your doctor find that the medication is effective and safe for managing your condition, you will likely continue receiving it for an extended period. The decision to continue treatment is always made in collaboration with your healthcare provider, based on your response to the therapy and overall health status.
It is vital to maintain open communication with your doctor throughout your treatment with Onpattro. You should consult your doctor if:
Your healthcare team is there to support you and ensure your treatment is as safe and effective as possible. They will monitor your progress and make any necessary adjustments to your treatment plan.
hATTR amyloidosis is a complex condition that requires specialized medical care. Early diagnosis and appropriate treatment are key to managing its progression and improving quality of life. Onpattro represents a significant advancement in the treatment of this rare disease, offering hope and improved outcomes for many patients.
Onpattro is a vital medication for individuals suffering from polyneuropathy due to hATTR amyloidosis. Understanding its administration, dosage, and the importance of adhering to the treatment schedule is crucial for successful management. Always rely on your healthcare provider for accurate information and guidance regarding your treatment.
Visit Hospital
Near You

Can a simple blood draw really predict dementia decades before memory problems start? In 2026, several major studies said yes β one found a protein called p-tau217 predicted risk up to 25 years ahead in women, while another found a 78% risk of cognitive impairment within 10 years in people with the
July 23, 2026

Learn about Parkinson's disease symptoms, causes, stages, and treatment options. A complete guide for patients and caregivers in simple language.
June 13, 2026
Seeking a brain specialist in Kamarhati? Doctar connects you with leading neurologists and neurosurgeons for expert care. Book appointments now.
May 20, 2026